Tentang Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. is an American specialty pharmaceutical company. It mainly markets products for treatment in neurology, pain and diseases of the central nervous system. Depomed was founded in 1995 and is headquartered in Newark, California. It is a publicly traded company on NASDAQ, with several products approved by the United States Food and Drug Administration (FDA). On August 15, 2018, the company announced its name change from Depomed, Inc., to Assertio Therapeutics, Inc. As of 2019, Assertio markets three products approved by the FDA: Gralise, Cambia, and Zipsor.
Source: Wikipedia
Kantor pusat251 LITTLE FALLS DRIVE, 19808, WILMINGTON, US
Berdiri2018
StatusAktif
Paten1 paten
GASTRIC RETENTIVE PHARMACEUTICAL COMPOSITIONS FOR TREATMENT AND PREVENTION OF CNS DISORDERSEP2326310B1 · 2019
Ulasan
Belum ada ulasan. Pernah bekerja dengan Assertio Therapeutics, Inc.? Jadilah yang pertama membagikan pengalaman Anda.
Informasi hukum
| Nama hukum | Assertio Therapeutics, Inc. |
|---|---|
| LEI | 549300L2A9NTF1JVDP20Lihat di GLEIF ↗ |
| Alamat terdaftar | 251 LITTLE FALLS DRIVE, 19808, WILMINGTON, US |
| Status | Aktif |
Sumber: GLEIF · diperbarui 16 Okt. 2026
Kontak & tautan
Lokasi
251 LITTLE FALLS DRIVE, 19808, WILMINGTON, US
Apakah ini perusahaan Anda?
Klaim halaman ini gratis untuk menambahkan logo, produk, foto, dan pekerjaan, serta menjawab ulasan.
Klaim halaman iniBergabung dengan Heelky untuk terhubung, merekrut, dan berkembang
Buat akun gratis untuk mengirim pesan, melamar pekerjaan, dan memposting misi.
Gabung sekarang — gratis